Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration.
T J Hahn, … , S L Teitelbaum, B H Hahn
T J Hahn, … , S L Teitelbaum, B H Hahn
Published August 1, 1979
Citation Information: J Clin Invest. 1979;64(2):655-665. https://doi.org/10.1172/JCI109506.
View: Text | PDF
Research Article Article has an altmetric score of 3

Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration.

  • Text
  • PDF
Abstract

Parameters of mineral and bone metabolism were studied in 17 patients treated chronically with supraphysiologic doses of glucocorticoids. When compared to 15 matched normal subjects, the patient group exhibited similar serum 25-hydroxyvitamin D (25-OHD) levels, decreased intestinal 47Ca absorption, increased serum immunoreactive parathyroid hormone, and decreased forearm bone mass. Iliac crest bone biopsies revealed a decreased bone formation rate and increased osteoclast number. Treatment with 25-OHD (mean dose 4.03 micrograms/d) and calcium (500 mg/d) in nine patients produced a 46% increase in 47Ca absorption (P less than 0.001) and a 54% decrease in serum immunoreactive parathyroid hormone (P less than 0.001) by 3 mo. In addition, by 12 mo the treatment group exhibited (a) a 13.2 +/- 5.1% increase in metaphyseal (P less than 0.001) and a 2.1 +/- 0.4% increase in diaphyseal (P less than 0.05) forearm bone mass, and (b) significant decreases in cortical and endosteal osteoclast number. Biochemical and bone mass changes persisted through 18 mo. No significant changes in any parameter occurred in eight control patients administered calcium 100 mg/d. It is concluded that treatment with 25-OHD and calcium can significantly improve parameters of mineral and bone metabolism in patients with glucocorticoid-induced osteopenia.

Authors

T J Hahn, L R Halstead, S L Teitelbaum, B H Hahn

×

Total citations by year

Year: 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 1984 1983 1982 1981 1980 1975 1974 Total
Citations: 2 1 1 2 1 1 3 4 2 4 5 4 9 4 1 2 4 5 5 8 6 6 6 6 10 13 10 7 10 6 11 7 13 7 13 8 6 12 8 16 6 7 5 4 1 1 273
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (273)

Title and authors Publication Year
Determinants and Effects of Vitamin D Supplementation in Postmenopausal Women: A Systematic Review.
Hassanein MM, Huri HZ, Baig K, Abduelkarem AR
Nutrients 2023
Vitamin D Deficiency in Chronic Childhood Disorders: Importance of Screening and Prevention.
Joshi M, Uday S
Nutrients 2023
Functional hypothalamic amenorrhea: Impact on bone and neuropsychiatric outcomes.
Pedreira CC, Maya J, Misra M
Frontiers in Endocrinology 2022
Outcomes of Femoral Neck Fracture Treated With Hip Arthroplasty in Solid Organ Transplant Patients
CK Ledford, MJ VanWagner, AC Spaulding, LS Spencer-Gardner, BK Wilke, SB Porter
Arthroplasty Today 2021
Comparative Serum Analyses Identify Cytokines and Hormones Commonly Dysregulated as Well as Implicated in Promoting Osteolysis in MMP-2-Deficient Mice and Children
H Sarker, E Hardy, A Haimour, MA Karim, S Scholl-Bürgi, JA Martignetti, LD Botto, C Fernandez-Patron
Frontiers in physiology 2020
Biological and microbiological interactions of Ti-35Nb-7Zr alloy and its basic elements on bone marrow stromal cells: good prospects for bone tissue engineering
D de Camargo Reis Mello, LM Rodrigues, FZ Mello, TF Gonçalves, B Ferreira, SG Schneider, LD de Oliveira, LM de Vasconcellos
International Journal of Implant Dentistry 2020
Rheumatic and Musculoskeletal Adverse Events with Immune Checkpoint Inhibitors: Data from the United States Food and Drug Administration Adverse Event Reporting System
XN Pundole, M Sarangdhar, ME Suarez-Almazor
2019
A Practical Approach to Adolescent Bone Health
S Pitts, CM Gordon
2018
Effects of Cholecalciferol vs Calcifediol on Total and Free 25-Hydroxyvitamin D and Parathyroid Hormone
A Shieh, C Ma, RF Chun, S Witzel, B Rafison, HT Contreras, J Wittwer-Schegg, L Swinkels, T Huijs, M Hewison, JS Adams
The Journal of clinical endocrinology and metabolism 2017
25(OH)D3-enriched or fortified foods are more efficient at tackling inadequate vitamin D status than vitamin D3
J Guo, JA Lovegrove, DI Givens
Proceedings of the Nutrition Society 2017
Hypothalamic Amenorrhea and the Long-Term Health Consequences
C Shufelt, T Torbati, E Dutra
Seminars in reproductive medicine 2017
Vitamin D3 and calcidiol are not equipotent
C Navarro-Valverde, M Sosa-Henríquez, MR Alhambra-Expósito, JM Quesada-Gómez
The Journal of Steroid Biochemistry and Molecular Biology 2016
Nutritional Influences on Bone Health
CM Weaver, S Jakeman
Nutritional Influences on Bone Health 2016
Adrenal disorders: Is there Any role for vitamin D?
G Tirabassi, G Salvio, B Altieri, CL Ronchi, SD Casa, A Pontecorvi, G Balercia
Reviews in Endocrine and Metabolic Disorders 2016
The Hypothalamic-Pituitary-Adrenal Axis in Health and Disease
EB Geer
The Hypothalamic-Pituitary-Adrenal Axis in Health and Disease 2016
The Role of MKP-1 in the Anti-Proliferative Effects of Glucocorticoids in Primary Rat Pre-Osteoblasts
M Sanderson, HS Gijsen, S Hough, WF Ferris, G Papaccio
PloS one 2015
The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF)
L Cianferotti, C Cricelli, JA Kanis, R Nuti, JY Reginster, JD Ringe, R Rizzoli, ML Brandi
Endocrine 2015
Controlling stem cell-mediated bone regeneration through tailored mechanical properties of collagen scaffolds
H Sun, F Zhu, Q Hu, PH Krebsbach
Biomaterials 2014
Pharmacokinetics of oral vitamin D3 and calcifediol
A Jetter, A Egli, B Dawson-Hughes, HB Staehelin, E Stoecklin, R Goessl, J Henschkowski, HA Bischoff-Ferrari
Bone 2014
The relationship between insulin, insulin resistance, parathyroid hormone, cortisol, testosterone, and thyroid function tests in the presence of nephrolithiasis: a comprehensive analysis
B Afsar, H Karaca
Central European Journal of Urology 2014
Moderate Zinc Supplementation During Prolonged Steroid Therapy Exacerbates Bone Loss in Rats
R Kamal, SC Bansal, N Khandelwal, DV Rai, DK Dhawan
Biological Trace Element Research 2014
Seldin and Giebisch's The Kidney
CJ Cooper, LD Dworkin, WL Henrich
Seldin and Giebisch's The Kidney 2013
Management of Complications in Oral and Maxillofacial Surgery: Miloro/Management of Complications in Oral and Maxillofacial Surgery
M Smith, F Williams, BB Ward
Management of Complications in Oral and Maxillofacial Surgery: Miloro/Management of Complications in Oral and Maxillofacial Surgery 2013
Vitamin D status and dietary intake in a Swedish COPD population: Vitamin D status and dietary intake in COPD
C Måhlin, H Sydow, A Osmancevic, M Emtner, AM Grönberg, S Larsson, F Slinde
The Clinical Respiratory Journal 2013
Calcidiol [25(Oh)D3]: From Diagnostic Marker To Therapeutical Agent
ML Brandi, S Minisola
Current Medical Research and Opinion 2013
Pathological fractures in paediatric patients with inflammatory bowel disease
SC Wong, AG Catto-Smith, M Zacharin
European Journal of Pediatrics 2013
Do Glucocorticosteroids Alter Vitamin D Status? A Systematic Review with Meta-Analyses of Observational Studies
ZE Davidson, KZ Walker, H Truby
The Journal of clinical endocrinology and metabolism 2012
Corticosteroid-Induced Osteoporosis : An Update for Dermatologists
BL Clarke
American Journal of Clinical Dermatology 2012
Corticosteroid-Induced Osteoporosis: An Update for Dermatologists
BL Clarke
American Journal of Clinical Dermatology 2012
Glucocorticoid use in children: The problems and solutions
TR Godbole, P Dabadghao
Indian Journal of Rheumatology 2012
Extrinsic Mechanisms Involved in Age-Related Defective Bone Formation
PJ Marie, M Kassem
The Journal of clinical endocrinology and metabolism 2011
Osteoporosis following organ transplantation: pathogenesis, diagnosis and management
K Sakhaee
Expert Review of Endocrinology & Metabolism 2011
Oral supplementation with 25(OH)D3 versus vitamin D3: Effects on 25(OH)D levels, lower extremity function, blood pressure, and markers of innate immunity
HA Bischoff-Ferrari, B Dawson-Hughes, E Stöcklin, E Sidelnikov, WC Willett, JO Edel, HB Stähelin, S Wolfram, A Jetter, J Schwager, J Henschkowski, A Eckardstein, A Egli
Journal of Bone and Mineral Research 2011
Osteoporosis inducida por corticoides
C Marcelli
EMC - Aparato Locomotor 2011
Glucocorticoids and Vitamin D
P Sambrook
Vitamin D 2011
Drug and Hormone Effects on Vitamin D Metabolism
BM Weinstein, S Epstein
Vitamin D 2011
The Role of Vitamin D in Osteoarthritis and Rheumatic Disease
MK Shea, TE McAlindon
Vitamin D 2011
Cushing's Disease in an Obese Patient Accompanied by Recurrent Urinary Tract Infection and Nephrolithiasis
S Hyun, JW Kim, MK Hong, MY Kim, SE Lee, SH Lee, J Kim, J Ahn
The Korean Journal of Obesity 2011
Ostéoporose cortisonique
C Marcelli
EMC - Appareil locomoteur 2011
Osteogenic differentiation of human amniotic fluid-derived stem cells induced by bone morphogenetic protein-7 and enhanced by nanofibrous scaffolds
H Sun, K Feng, J Hu, S Soker, A Atala, PX Ma
Biomaterials 2010
Indications on the use of vitamin D and vitamin D metabolites in clinical phenotypes
ML Brandi
Clinical Cases in Mineral and Bone Metabolism 2010
Drugs and Appetite: An Overview of Appetite Stimulants in the Pediatric Patient
K Gura, R Ciccone
ICAN: Infant, Child, & Adolescent Nutrition 2010
Steroid withdrawal in renal transplant patients: the Irish experience
PJ Phelan, AM Moran, P OKelly, PY Heng, SM Yussof, JJ Walshe, C Magee, PJ Conlon
Irish Journal of Medical Science 2010
Osteoporosi e malattie metaboliche dell’osso
CV Albanese, R Passariello
2009
Principles of Bone Biology
CJ Rosen, T Niu
Principles of Bone Biology 2008
Patogenia de la osteoporosis esteroidea
BE Riera, J González-Macías
Revista Española de Enfermedades Metabólicas Óseas 2008
Total Burn Care
SE Morris
Total Burn Care 2007
Alendronate versus alfacalcidol in the prevention of glucocorticoid-induced bone loss
BH Hahn, TJ Hahn
Nature Clinical Practice Rheumatology 2007
Osteoporosis in Men
L Gennari, JP Bilezikian
Endocrinology & Metabolism Clinics of North America 2007
Glucocorticosteroid-induced osteoporosis in adult primiparous Göttingen miniature pigs: effects on bone mineral and mineral metabolism
KE Scholz-Ahrens, G Delling, B Stampa, A Helfenstein, HJ Hahne, Y Açil, W Timm, R Barkmann, J Hassenpflug, J Schrezenmeir, CC Glüer
American journal of physiology. Endocrinology and metabolism 2007
Glucocorticosteroid-induced spinal osteoporosis: scientific update on pathophysiology and treatment
AW Popp, J Isenegger, EM Buergi, U Buergi, K Lippuner
European Spine Journal 2006
Beneficial Effects of Extended Growth Hormone Treatment After Hospital Discharge in Pediatric Burn Patients
R Przkora, DN Herndon, OE Suman, MG Jeschke, WJ Meyer, DL Chinkes, RP Mlcak, T Huang, RE Barrow
Annals of Surgery 2006
Growth, Bone Mineral Accretion, and Adrenal Function in Glucocorticoid-Treated Infants with Hemangiomas - A Retrospective Study
JP Lomenick, PF Backeljauw, AW Lucky
Pediatric Dermatology 2006
Effect of kidney transplantation on bone
K Kodras, M Haas
European Journal of Clinical Investigation 2006
Osteoporosis in Health and Disease: A Dermatologist's Perspective
A Lamb, V Werth
Dermatologic Clinics 2006
Glucocorticoid-Induced Osteoporosis: From Basic Mechanisms to Clinical Aspects
S Alesci, MU de Martino, I Ilias, PW Gold, GP Chrousos
Neuroimmunomodulation 2005
Canine hyperadrenocorticism: effects of trilostane on parathyroid hormone, calcium and phosphate concentrations
AJ Tebb, A Arteaga, H Evans, IK Ramsey
Journal of Small Animal Practice 2005
Hyperparathyroidism in dogs with hyperadrenocorticism
IK Ramsey, A Tebb, E Harris, H Evans, ME Herrtage
Journal of Small Animal Practice 2005
NeuroImmune Biology
R Solana, G Pawelec
NeuroImmune Biology 2005
Bone Disease of Organ Transplantation
MR Rubin, JP Billezkian
Bone Disease of Organ Transplantation 2005
Perspectives on glucocorticoid-induced osteoporosis
E Canalis, JP Bilezikian, A Angeli, A Giustina
Bone 2004
Protective effect of vitamins K2 and D3 on prednisolone-induced loss of bone mineral density in the lumbar spine
K Yonemura, H Fukasawa, Y Fujigaki, A Hishida
American Journal of Kidney Diseases 2004
Management of neuropathic injury to the tarsal navicular
EM Bluman, MS Myerson
Foot and Ankle Clinics 2004
Principles of Gender-Specific Medicine
G Supinski, LA Callahan
Principles of Gender-Specific Medicine 2004
Nutrition and Bone Health
MF Holick, B Dawson-Hughes
2004
Elements and Their Compounds in the Environment: Occurrence, Analysis and Biological Relevance
E Merian, M Anke, M Ihnat, M Stoeppler
2004
Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies
RN de Nijs, JW Jacobs, A Algra, WF Lems, JW Bijlsma
Osteoporosis International 2004
Oral glucocorticoid use is associated with an increased risk of fracture
M Steinbuch, TE Youket, S Cohen
Osteoporosis International 2004
Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study
CD Somma, R Pivonello, S Loche, A Faggiano, M Klain, M Salvatore, G Lombardi, A Colao
Clinical Endocrinology 2003
Bone disease after renal transplantation
JG Heaf
Transplantation 2003
AGA technical review on osteoporosis in gastrointestinal diseases
CN Bernstein, WD Leslie, MS Leboff
Gastroenterology 2003
Mechanisms of glucocorticoid-induced osteoporosis
Ernesto Canalis
Current Opinion in Rheumatology 2003
Nephrolithiasis in Cushing’s Disease: Prevalence, Etiopathogenesis, and Modification after Disease Cure
A Faggiano, R Pivonello, D Melis, M Filippella, CD Somma, M Petretta, G Lombardi, A Colao
The Journal of clinical endocrinology and metabolism 2003
Bone mineral density and bone metabolism in Duchenne muscular dystrophy
ML Bianchi, A Mazzanti, E Galbiati, S Saraifoger, A Dubini, F Cornelio, L Morandi
Osteoporosis International 2003
Vitamin K2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats
K Hara, M Kobayashi, Y Akiyama
Bone 2002
Clinical physiology and pathology of the growth plate
Z Hochberg
Best Practice & Research Clinical Endocrinology & Metabolism 2002
Severe impairment of bone mass and turnover in Cushing's disease: comparison between childhood-onset and adulthood-onset disease
CD Somma, R Pivonello, S Loche, A Faggiano, P Marzullo, AD Sarno, M Klain, M Salvatore, G Lombardi, A Colao
Clinical Endocrinology 2002
The impact of corticosteroids on growth and bone health
T Mushtaq, SF Ahmed
Archives of disease in childhood 2002
Mechanisms of glucocorticoid action in bone
Ernesto Canalis, Anne M Delany
Annals of the New York Academy of Sciences 2002
The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol1:
HU Stempfle, C Werner, U Siebert, T Assum, U Wehr, WA Rambeck, B Meiser, K Theisen, R Grtner
Transplantation 2002
Glucocorticoid-induced osteoporosis
R Kumar
Current Opinion in Nephrology and Hypertension 2001
Alendronate for the prevention of bone loss in patients on inhaled steroid therapy
EM Lau, J Woo, YH Chan, M Li
Bone 2001
An Update on Glucocorticoid-Induced Osteoporosis
NE Lane
Rheumatic Disease Clinics of North America 2001
Corticosteroid osteoporosis
P Sambrook, NE Lane
Best Practice & Research Clinical Rheumatology 2001
TREATMENT OF ESTABLISHED BONE LOSS AFTER RENAL TRANSPLANTATION WITH ETIDRONATE1:
DJ Arlen, K Lambert, G Ioannidis, JD Adachi
Transplantation 2001
Corticosteroid-Induced Osteoporosis: Detection and Management
JD Adachi, A Papaioannou
Drug Safety 2001
Acid and mineral balances and bone in familial proximal renal tubular acidosis
J Lemann, ND Adams, DR Wilz, LG Brenes
Kidney International 2000
Management of corticosteroid-induced osteoporosis
JD Adachi, WP Olszynski, DA Hanley, AB Hodsman, DL Kendler, KG Siminoski, J Brown, EA Cowden, D Goltzman, G Ioannidis, RG Josse, LG Ste-Marie, AM Tenenhouse, KS Davison, KL Blocka, AP Pollock, J Sibley
Seminars in Arthritis and Rheumatism 2000
Sheep Model for Fracture Treatment in Osteoporotic Bone: A Pilot Study About Different Induction Regimens
CA Lill, AK Fluegel, E Schneider
Journal of Orthopaedic Trauma 2000
Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology
EM Scott, I Gaywood, BB Scott
Gut 2000
STEROID–INDUCED OSTEOPOROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS
G Cunnane, NE Lane
Rheumatic Disease Clinics of North America 2000
Corticosteroids and osteoporosis
PM Williford
Current Problems in Dermatology 2000
Metabolic bone disease in adults with inflammatory bowel disease
JD Adachi, A Rostom
Inflammatory Bowel Diseases 1999
Glucocorticoid Osteoporosis
IR Reid
Journal of Intensive Care Medicine 1999
Increased reduction in bone density and skin thickness in postmenopausal women taking long-term corticosteroid therapy: a suggested role for estrogen add-back therapy
YM Baron, MP Brincat, R Galea
Climacteric 1999
Prevention of glucocorticoid-induced osteoporosis: provider practice at an urban county hospital
EM Aagaard, P Lin, GW Modin, NE Lane
The American Journal of Medicine 1999
Metabolic Bone Disease in Adults with Inflammatory Bowel Disease:
JD Adachi, A Rostom
Inflammatory Bowel Diseases 1999
Glucocorticoid Osteoporosis: Reid IR Glucocorticoid osteoporosis J Intensive Care Med 1999, 14231-242
IR Reid
Journal of Intensive Care Medicine 1999
Delayed Pubertal Growth Spurt and Normal Adult Height Attainment in Boys Receiving Long-term Alternate-day Prednisone Therapy
C Polito, AL Manna, MR Papale, G Villani
Clinical Pediatrics 1999
The role of vitamin D in corticosteroid-induced osteoporosis: A meta-analytic approach
S Amin, MP LaValley, RW Simms, DT Felson
Arthritis & Rheumatism 1999
PREVENTION OF OSTEOPOROSIS AFTER CARDIAC TRANSPLANTATION: A Prospective, Longitudinal, Randomized, Double-Blind Trial with Calcitriol1
HU Stempfle, C Werner, S Echtler, U Wehr, WA Rambeck, U Siebert, P derfuhr, CE Angermann, K Theisen, R Grtner
Transplantation 1999
Rheumaderm
C Mallia, J Uitto
1999
Osteopathy in Broiler Chicks Fed Toxic Mimosine in Leucaena leucocephala
Y KAMADA, N OSHIRO, M MIYAGI, H OKU, F HONGO, I CHINEN
Bioscience, Biotechnology, and Biochemistry 1998
Effects of short-term treatment with prednisolone and calcitriol on bone and mineral metabolism in normal men
J Gram, P Junker, HK Nielsen, J Bollerslev
Bone 1998
Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease
CD Somma, A Colao, R Pivonello, M Klain, A Faggiano, FS Tripodi, B Merola, M Salvatore, G Lombardi
Clinical Endocrinology 1998
Development and Characterization of Conditionally Immortalized Osteoblast Precursor Cell Lines from Human Bone Marrow Stroma
KC Hicok, T Thomas, F Gori, DJ Rickard, TC Spelsberg, BL Riggs
Journal of Bone and Mineral Research 1998
Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
KG Saag, R Emkey, TJ Schnitzer, JP Brown, F Hawkins, S Goemaere, G Thamsborg, UA Liberman, PD Delmas, MP Malice, M Czachur, AG Daifotis, N Lane, R Correa-Rotter, M Yanover, R Westhovens, S Epstein, JD Adachi, P Poubelle, J Melo-Gomes, JA Rodriguez-Portales
New England Journal of Medicine 1998
Glucocorticoid-Induced Osteoporosis
IR Reid
Journal of Clinical Densitometry 1998
Prévenir et traiter l'ostéoporose cortico-induite
E Hachulla, B Cortet
La Revue de Médecine Interne 1998
THE SCIENCE AND THERAPY OF GLUCOCORTICOID-INDUCED BONE LOSS
NE Lane, B Lukert
Endocrinology and metabolism clinics of North America 1998
Calcium in Corticosteroid-Induced Osteoporosis
KH Lucas, SM Davis
The Annals of pharmacotherapy 1998
Inhibition of Mitogen-Activated Protein Kinase Activity and Proliferation of an Early Osteoblast Cell Line (MBA 15.4) by Dexamethasone: Role of Protein Phosphatases*
PA Hulley, F Gordon, FS Hough
Endocrinology 1998
Corticosteroid-Induced Bone Loss in Men
G Pearce, DA Tabensky, PD Delmas, HW Baker, E Seeman
The Journal of clinical endocrinology and metabolism 1998
Prevention and treatment of glucocorticoid-induced osteoporosis
F Eggelmeijer
Pharmacy World & Science 1998
Vitamin E for intermittent claudication
J Kleijnen, D Mackerras
Cochrane Database of Systematic Reviews 1998
Corticosteroid-Induced Osteoporosis
JD Adachi
The American Journal of the Medical Sciences 1997
Prevention of corticosteroid-induced bone loss with nitric oxide donor nitroglycerin in male rats
SJ Wimalawansa, MT Chapa, C Yallampalli, R Zhang, DJ Simmons
Bone 1997
Active vitamin D metabolites in glucocorticoid-induced osteoporosis
JD Ringe
Calcified Tissue International 1997
Dexamethasone Stimulates Osteoclast-like Cell Formation by Directly Acting on Hemopoietic Blast Cells and Enhances Osteoclast-like Cell Formation Stimulated by Parathyroid Hormone and Prostaglandin E2
H Kaji, T Sugimoto, M Kanatani, K Nishiyama, K Chihara
Journal of Bone and Mineral Research 1997
Steroid-induced osteoporosis
IR Reid
Osteoporosis International 1997
Osteoporosis
DL Glaser, FS Kaplan
Spine 1997
Which treatments are effective in preventing and treating glucocorticoid-induced bone loss: Comment on the american college of rheumatology recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis
PN Sambrook
Arthritis & Rheumatism 1997
Corticosteroid-Induced Osteoporosis:
JD Adachi
The American Journal of the Medical Sciences 1997
8 How do we manage specific types of osteoporosis?
PN Sambrook, V Naganathan
Baillière's Clinical Rheumatology 1997
Adverse Effects of Corticosteroid Therapy for COPD
CE McEvoy, DE Niewoehner
Chest 1997
Qualitative alterations of cortical bone in female rats after long-term administration of growth hormone and glucocorticoid
G Ørtoft
Bone 1996
Resistance exercise training restores bone mineral density in heart transplant recipients
RW Braith, RM Mills, MA Welsch, JW Keller, ML Pollock
Journal of the American College of Cardiology 1996
Dexamethasone regulation of marrow stromal-derived osteoblastic cells
A Fried, D Benayahu
Journal of Cellular Biochemistry 1996
Effects of a synthetic vitamin D analog, ED-71, on bone dynamics and strength in cancellous and cortical bone in prednisolone-treated rats
Y Tanaka, T Nakamura, S Nishida, K Suzuki, S Takeda, K Sato, Y Nishii
Journal of Bone and Mineral Research 1996
PREVENTION OF BONE LOSS IN CARDIAC TRANSPLANT RECIPIENTS: A Comparison of Biphosphonates and Vitamin D
JV Cleemput, W Daenen, P Geusens, J Dequeker, FV de Werf, J Vanhaecke
Transplantation 1996
Comprehensive Human Physiology
R Greger, U Windhorst
1996
Corticosteroid-Induced Bone Loss: Prevention and Management
C Picado, M Luengo
Drug Safety 1996
Changes in calcium and bone metabolism during treatment with low dose prednisone in young, healthy, male volunteers
WF Lems, JW Jacobs, HJ Rijn, JW Bijlsma
Clinical Rheumatology 1995
Growth hormone is not able to counteract osteopenia of rat cortical bone induced by Glucocorticoid with protracted effect
G Ørtoft, A Brüel, TT Andreassen, H Oxlund
Bone 1995
Intact parathyroid hormone levels are not elevated in glucocorticoid-treated subjects
E Paz-Pacheco, GE Fuleihan, MS Leboff
Journal of Bone and Mineral Research 1995
Musculoskeletal complications of systemic lupus erythematosus in the hopkins lupus cohort: An update
M Petri
Arthritis Care & Research 1995
Cyclical edidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis
A Struys, AA Snelder, H Mulder
The American Journal of Medicine 1995
Osteoporosis in Glucocorticoid-Dependent Asthmatic Patients: Literature Review and Recommendations
M Schatz, D Hamilos
Clinical immunotherapeutics 1995
The Effect of Glucocorticoids on Osteoblast Function. The Effect of Corticosterone on Osteoblast Expression of Beta Sub 1 Integrins:
WJ Doherty, ME DeRome, MB McCarthy, GA Gronowicz
The Journal of Bone and Joint Surgery. American volume. 1995
Bone Mineral Content in Nephrotic Children on Long-Term, Alternate-Day Prednisone Therapy
C Polito, AL Manna, N Todisco, E Cimmaruta, G Sessa, M Pirozzi
Clinical Pediatrics 1995
Drug-Induced Metabolic Bone Disease
M Wolinsky-Friedland
Endocrinology and metabolism clinics of North America 1995
Progesterone receptors are expressed in human osteoblast-like cell lines and in primary human osteoblast cultures
P MacNamara, C O'Shaughnessy, P Manduca, HC Loughrey
Calcified Tissue International 1995
High-dose glucocorticoids in multiple sclerosis patients exert direct effects on the kidney and skeleton
F Cosman, J Nieves, J Herbert, V Shen, R Lindsay
Journal of Bone and Mineral Research 1994
Synthetic peptide containing Arg-Gly-Asp inhibits bone formation and resorption in a mineralizing organ culture system of fetal rat parietal bones
GA Gronowicz, ME Derome
Journal of Bone and Mineral Research 1994
Total Parenteral Nutrition and Its Effects on Bone Metabolism
GL Klein, JW Coburn, EW Lipkin
Critical Reviews in Clinical Laboratory Sciences 1994
Comprehensive Management of Menopause
J Lorrain, L Plouffe, VA Ravnikar, L Speroff, NB Watts
1994
CALCIUM, ESTROGEN, AND PROGESTIN IN THE TREATMENT OF OSTEOPOROSIS
NA Breslau
Rheumatic diseases clinics of North America 1994
GLUCOCORTICOID-INDUCED OSTEOPOROSIS
BP Lukert, LG Raisz
Rheumatic diseases clinics of North America 1994
The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women
GM Hall, TD Spector, AJ Griffin, AS Jawad, ML Hall, DV Doyle
Arthritis & Rheumatism 1993
Bone disease in burn patients
GL Klein, DN Herndon, TC Rutan, DJ Sherrard, JW Coburn, CB Langman, ML Thomas, JG Haddad, CW Cooper, NL Miller, AC Alfrey
Journal of Bone and Mineral Research 1993
Corticosteroid-induced osteoporosis
JD Adachi, WG Bensen, AB Hodsman
Seminars in Arthritis and Rheumatism 1993
Is Steroid-Induced Osteoporosis Preventable?
PJ Meunier
New England Journal of Medicine 1993
Effects of corticosteroids on bone turnover
DJ Hosking
Respiratory Medicine 1993
Bone metabolism in children with asthmatreated with inhaled beclomethasone dipropionate
P König, L Hillman, C Cervantes, C Levine, C Maloney, B Douglass, L Johnson, S Allen
The Journal of Pediatrics 1993
Surgical Endocrinology
M Press
Surgical Endocrinology 1993
Humoral Factors in the Regulation of Tissue Growth
PP Foà
1993
Bone metabolism before and after irradiation with ultraviolet light
A Falkenbach, U Unkelbach, BO Boehm, A Regeniter, J Stein, U Seiffert, T Wendt
European Journal of Applied Physiology and Occupational Physiology 1993
Glucocorticoid-induced inhibition of osteoblastic bone formation in ewes: A biochemical and histomorphometric study
P Chavassieux, P Pastoureau, MC Chapuy, PD Delmas, PJ Meunier
Osteoporosis International 1993
Bone loss after cardiac transplantation: Effects of calcium, calcidiol and monofluorophosphate
E Meys, F Terreaux-Duvert, T Beaume-Six, G Dureau, PJ Meunier
Osteoporosis International 1993
Management of corticosteroid-induced osteoporosis: A clinician's perspective
SL Silverman
Calcified Tissue International 1992
Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss
BP Lukert, BE Johnson, RG Robinson
Journal of Bone and Mineral Research 1992
Effects of deflazacort on aspects of bone formation in cultures of intact calvariae and osteoblast-enriched cells
E Canalis, L Avioli
Journal of Bone and Mineral Research 1992
Bone histomorphometry in Cushing’s syndrome
A Borelli, MO Leite, PH Correa, V Jorgetti, JA Marcondes, JR Batalha, AB Cintra, BL Wajchenberg
Journal of Endocrinological Investigation 1992
Steroid interactions affecting metabolic activities of a T-lymphocyte line
CK Osterland, EA Louis, AJ Antakly, JM Esdaile
International Journal of Immunopharmacology 1992
The effect of corticosteroid-induced osteoporosis on orthodontic tooth movement
MB Ashcraft, KA Southard, EA Tolley
American Journal of Orthodontics and Dentofacial Orthopedics 1992
Serum blocks the osteolytic effect of cortisol in neonatal mouse calvaria
C Lowe, DH Gray, IR Reid
Calcified Tissue International 1992
Is there an effective treatment for glucocorticoid-induced osteoporosis?
DT Villareal, R Civitelli, C Gennari, LV Avioli
Calcified Tissue International 1991
Prevention and treatment of osteopenia in the ovariectomized rat: Effect of combined therapy with estrogens, 1-alpha vitamin D, and prednisolone
P Geusens, J Dequeker, J Nijs, A Verstraeten, E Bramm
Calcified Tissue International 1991
Effect of Glucocorticoids on Bone Gla Protein Values -BGP as a Good Marker of Osteoporosis-
T Iwasaki
Pediatrics International 1991
Osteoporosis associated with rheumatoid arthritis: Pathogenesis and management
I Joffe, S Epstein
Seminars in Arthritis and Rheumatism 1991
A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders
RE Gray, SM Doherty, J Galloway, L Coulton, JA Kanis, M Broe
Arthritis & Rheumatism 1991
Acute effect of 1,25-dihydroxyvitamin D3, prednisone, and 1,25-dihydroxyvitamin D3 plus prednisone on serum osteocalcin in normal individuals
HK Nielsen, K Brixen, M Kassem, L Mosekilde
Journal of Bone and Mineral Research 1991
Rheumatology
RA Asherson, R Cervera, DP D'Cruz, GR Hughes
Postgraduate medical journal 1991
Ostéoporose cortisonique: de la physiopathologie au traitement
M Audran, MF Basle
La Revue de Médecine Interne 1991
Glucocorticoid-induced osteoporosis: a cross-sectional study
DW Brandli, G Golde, M Greenwald, SL Silverman
Steroids 1991
Locomotor side-effects of corticosteroids
P Geusens, J Dequeker
Baillière's Clinical Rheumatology 1991
The assessment of the systemic effects of inhaled glucocorticosteroids: The effects of inhaled budesonide vs oral prednisolone on calcium metabolism
BH Jennings, KE Andersson, S Johansson
European Journal of Clinical Pharmacology 1991
Assessment of systemic effects of inhaled glucocorticosteroids: comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover
BH Jennings, , S Johansson
European Journal of Clinical Pharmacology 1991
Osteologie — interdisziplinär
E Werner, HH Matthiaß
1991
Effective therapy of glucocorticoid-induced osteoporosis with medroxyprogesterone acetate
EO Grecu, A Weinshelbaum, R Simmons
Calcified Tissue International 1990
Glucocorticoids stimulate resorption in fetal rat parietal bones in vitro
G Gronowicz, MB McCarthy, LG Raisz
Journal of Bone and Mineral Research 1990
The long-term treatment of steroid osteoporosis with fluoride
TA Bayley, C Muller, J Harrison, J Basualdo, W Sturtridge, R Josse, TM Murray, KP Pritzker, R Vieth, S Goodwin, A Strauss
Journal of Bone and Mineral Research 1990
Corticosteroid-induced Osteoporosis
SF Hodgson
Endocrinology and metabolism clinics of North America 1990
Geriatric Medicine
CK Cassel, DE Riesenberg, LB Sorensen, JR Walsh
1990
Inflammatory Bowel Diseases 1990
D Rachmilewitz, J Zimmerman
1990
Steroid-Induced Osteoporosis
RS Bockman, SA Weinerman
Orthopedic Clinics of North America 1990
PATHOGENESIS AND TREATMENT OF STEROID OSTEOPOROSIS
IR Reid
Clinical Endocrinology 1989
Steroid osteoporosis
IR Reid
Calcified Tissue International 1989
Glucocorticoid-induced osteoporosis
JD Ringe
Clinical Rheumatology 1989
Corticosteroids in rheumatoid arthritis
MM Weiss
Seminars in Arthritis and Rheumatism 1989
Glucocorticoid-induced osteoporosis: Pathogenesis, prevention and treatment
LG Raisz, BP Lukert
Journal of Bone and Mineral Metabolism 1989
A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: Hepatic improvement but greater bone loss
HC Mitchison, MF Bassendine, AJ Malcolm, AJ Watson, CO Record, OF James
Hepatology 1989
Perspectives bone histomorphometry in glucocorticoid-induced osteoporosis
DW Dempster
Journal of Bone and Mineral Research 1989
Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia
SA Atkinson, L Fraher, CM Gundberg, M Andrew, M Pai, RD Barr
The Journal of Pediatrics 1989
Animal Growth Regulation
DR Campion, GJ Hausman, RJ Martin
1989
Neuere Ergebnisse in der Osteologie
HG Willert, FH Heuck
1989
Modern Therapeutic Approaches to Osteoporosis
KL Sewell
Rheumatic diseases clinics of North America 1989
Low-Dose Prednisone Therapy
WP Docken
Rheumatic diseases clinics of North America 1989
Prevention of glucocorticoid-induced osteopenia: Effect of oral 25-hydroxyvitamin D and calcium
OD Munno, F Beghe, P Favini, PD Giuseppe, A Pontrandolfo, G Occhipinti, G Pasero
Clinical Rheumatology 1989
Vitamin D
A Portale, Β Halloran, E Lonergan, R Morris
Vitamin D 1988
Effect of glucocorticoid administration on intestinal, renal, and cerebellar calbindin-D28K in chicks
M Tohmon, M Fukase, M Kishihara, S Kadowaki, T Fujita
Journal of Bone and Mineral Research 1988
PREVENTION OF STEROID-INDUCED OSTEOPOROSIS WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (APD)
IR Reid, CJ Alexander, AR King, HK Ibbertson
The Lancet 1988
Effects of moderate physical training on prednisone-induced protein wasting: A study of whole-body and bone protein metabolism
DR Garrel, PD Delmas, C Welsh, MJ Arnaud, SE Hamilton, MM Pugeat
Metabolism 1988
5 Management of osteoporosis
R Lindsay
Baillière's Clinical Endocrinology and Metabolism 1988
Trabecular Bone Morphometry in Beagles with Hyperadrenocorticism and Adrenal Adenomas
RW Norrdin, TR Carpenter, BF Hamilton, RD Brewster
Veterinary pathology 1988
Glucocorticoids and inhibition of bone formation induced by skeletal unloading
BP Halloran, DD Bikle, CM Cone, E Morey-Holton
American journal of physiology. Endocrinology and metabolism 1988
Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis
AJ Stellon, A Webb, JE Compston
Gut 1988
Effects of long-term maintenance therapy with a new glucocorticoid, deflazacort, on mineral metabolism and statural growth
S Balsan, D Stéru, A Bourdeau, R Grimberg, G Lenoir
Calcified Tissue International 1987
Serum concentration of vitamin D metabolites in rheumatoid arthritis
OS Als, B Riis, C Christiansen
Clinical Rheumatology 1987
Psychosocial stress, dietary calcium and hypertension in the spontaneously hypertensive rat
PE Huie, DC Hatton, MS Muntzel, JA Metz, DA McCarron
Physiology & Behavior 1987
Osteopenia
GR Mundy
Disease-a-Month 1987
Serum steroid hormone profiles in postmenopausal smokers and nonsmokers**Supported in part by grant IND 13,530, an osteoporosis study with The Upjohn Company, Kalamazoo, Michigan; and data organization and analysis assisted by the CLINFO data management and analysis system at Brigham and Women’s Hospital, Boston, Massachusetts, supported by grant 7-M01-RR02635-01 from the General Clinical Research Center
AJ Friedman, VA Ravnikar, RL Barbieri
Fertility and Sterility 1987
Salmon calcitonin in the therapy of corticoid-induced osteoporosis
, D Welzel
European Journal of Clinical Pharmacology 1987
Influence of glucocorticoids on calcium absorption in different segments of the rat intestine
JK Yeh, JF Aloia
Calcified Tissue International 1986
The effects of hydrocortisone, parathyroid hormone and the bisphosphonate, APD, on bone resorption in neonatal mouse calvaria
IR Reid, JM Katz, HK Ibbertson, DH Gray
Calcified Tissue International 1986
Osteoporosis and aging: gastrointestinal aspects
B Dawson-Hughes
Journal of the American College of Nutrition 1986
Management of rheumatoid arthritis
CE Dugowson, BC Gilliland
Disease-a-Month 1986
Corticosteroids for rheumatic disease: 2. Effects on disease states, effects on bone
T Jamieson
Postgraduate Medicine 1986
Current Concepts of Bone Fragility
HK Uhthoff
1986
Clinical Endocrinology
A Labhart
Clinical Endocrinology 1986
Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica
DM Reid, JJ Nicoll, MA Smith, B Higgins, P Tothill, G Nuki
BMJ : British Medical Journal 1986
Contemporary Geriatric Medicine
SR Gambert
1986
Therapeutics in Rheumatology
JM Moll, HA Bird, A Rushton
1986
The treatment of osteoporosis
RA Melick
The Medical Journal of Australia 1986
The use of corticosteroid agents in connective tissue disorders ∗
D Barraclough
The Medical Journal of Australia 1986
Irreversible bone loss in osteomalacia. Comparison of radial photon absorptiometry with iliac bone histomorphometry during treatment
AM Parfitt, DS Rao, J Stanciu, AR Villanueva, M Kleerekoper, B Frame
Journal of Clinical Investigation 1985
Effects of vitamin D
G Sjödén
Acta Orthopaedica 1985
Bone mineral loss, bone histomorphometry and vitamin D metabolism in patients with rheumatoid arthritis on long-term glucocorticoid treatment
B Lund, TL Storm, B Lund, F Melsen, L Mosekilde, RB Andersen, C Egmose, OH Sørensen
Clinical Rheumatology 1985
Effects of prednisone and deflazacort on vertebral bone mass
C Gennarl, B Imbimbo
Calcified Tissue International 1985
Thigh muscle mass and function in patients treated with glucocorticoids
FF Horber, JR Scheidegger, BE Grünig, FJ Frey
European Journal of Clinical Investigation 1985
Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases
TR Dykman, OS Gluck, WA Murphy, TJ Hahn, BH Hahn
Arthritis & Rheumatism 1985
Bone loss in autoimmune chronic active hepatitis on maintenance corticosteroid therapy
AJ Stellon, A Davies, J Compston, R Williams
Gastroenterology 1985
Hypocalcaemia induced by glucocorticoids in a child with hypoparathyroidism treated with 1-?-hydroxyvitamin D3
P Vardi, A Benderly, A Etzioni, J Levy, Z Hochberg
European Journal of Pediatrics 1985
Glucocorticoids modulate macrophage surface oligosaccharides and their bone binding activity
Z Bar-Shavit, AJ Kahn, LE Pegg, KR Stone, SL Teitelbaum
Journal of Clinical Investigation 1984
Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans
C Gennari, B Imbimbo, M Montagnani, M Bernini, P Nardi, LV Avioli
Calcified Tissue International 1984
Osteopenia in rheumatology practice: Pathogenesis and therapy
H Tannenbaum
Seminars in Arthritis and Rheumatism 1984
Corticosteroids and bone
W Peck, C Gennari, L Raisz, P Meunier, E Ritz, S Krane, G Nuki, LV Avioli
Calcified Tissue International 1984
Comparative study of deflazacort, a new synthetic corticosteroid, and dexamethasone on the synthesis of collagen in different rat bone cell populations and rabbit articular chondrocytes
HL Guenther, R Felix, H Fleisch
Calcified Tissue International 1984
Mineral loss in cortical and trabecular bone during high-dose prednisone treatment
H Rickers, A Deding, C Christiansen, P Rødbro
Calcified Tissue International 1984
The ADFR concept revisited
HM Frost
Calcified Tissue International 1984
Calcium and glucose uptake in rat small intestinal brush-border membrane vesicles. Modulation by exogenous hypercortisolism and 1.25-dihydroxyvitamin D-3
HJ Braun, JC Birkenhäger, HR de Jonge
Biochimica et Biophysica Acta (BBA) - Biomembranes 1984
Low-dose prednisone therapy in rheumatoid arthritis: effect on vitamin d metabolism
JE Zerwekh, RD Emkey, ED Harris
Arthritis & Rheumatism 1984
Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases
TR Dykman, KM Haralson, OS Gluck, WA Murphy, SL Teitelbaum, TJ Hahn, BH Hahn
Arthritis & Rheumatism 1984
Determining causation—A case study: Adrenocorticosteroids and osteoporosis
GH Guyatt, CE Webber, AA Mewa, DL Sackett
Journal of Chronic Diseases 1984
Effect of prednisone on growth and zinc metabolism in rats
M Jacob, JC Chan, JC Smith
Nutrition Research 1984
Effects of Glucocorticoids on Endocrine Function in the Dog
RJ Kemppainen
Veterinary Clinics of North America Small Animal Practice 1984
Rheumatoid Arthritis: The Treatment Controversy
DH Goddard, RC Butler
1984
Chemical Abnormalities
WJ Burtis, R Lang
Orthopedic Clinics of North America 1984
Bone mineral content after renal transplantation: Placebo-controlled prospective study with 1,25-dihydroxy vitamin D3
E Neubauer, N Neubauer, E Ritz, K Dreikorn,
Klinische Wochenschrift 1984
Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis
DW Dempster, MA Arlot, PJ Meunier
Calcified Tissue International 1983
INFLUENCE OF 1α-(OH)D3ADMINISTRATION ON BONE AND BONE MINERAL METABOLISM IN PATIENTS ON CHRONIC GLUCOCORTICOID TREATMENT; A DOUBLE BLIND CONTROLLED STUDY
JJ Braun, DH Birkenhäger-Frenkel, AH Rietveld, JR Juttmann, TJ Visser, JC Birkenhäger
Clinical Endocrinology 1983
Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy
Y Suzuki, Y Ichikawa, E Saito, M Homma
Metabolism 1983
Regulation of Bone Formation
LG Raisz, BE Kream
New England Journal of Medicine 1983
Nutrition in the Middle and Later Years
BG Edwards
Nutrition in the Middle and Later Years 1983
Steroid-Induced Fractures and Bone Loss in Patients with Asthma
AD Adinoff, JR Hollister
New England Journal of Medicine 1983
Focal mineralization defect during disodium etidronate treatment of calcinosis
RS Weinstein
Calcified Tissue International 1982
CORTICOSTEROID-INDUCED OSTEOPENIA AND VITAMIN D METABOLISM. EFFECT OF VITAMIN D2, CALCIUM PHOSPHATE AND SODIUM FLUORIDE ADMINISTRATION
H Rickers, Å Deding, C Christiansen, P Rødbro, J Næstoft
Clinical Endocrinology 1982
Glucocorticoids down-regulate the number of 1,25-dihydroxyvitamin D3 receptors in mouse intestine
M Hirst, D Feldman
Biochemical and Biophysical Research Communications 1982
“Nutritional insurance” supplementation and corticosteroid toxicity
MF McCarty
Medical Hypotheses 1982
Disorders of Mineral Metabolism
RK Rude, FR Singer
Disorders of Mineral Metabolism 1982
Osteoporosis: Approaching treatment with optimism
LE Mallette
Postgraduate Medicine 1982
Glucocorticoid regulation of 1,25(OH)2-vitamin D3 receptors in cultured mouse bone cells
TL Chen, CM Cone, E Morey-Holton, D Feldman
The Journal of biological chemistry 1982
Protective effect on vitamin D2 on bone apposition from the inhibitory action of hydrocortisone in rats
CS Tam, DR Wilson, AJ Hitchman, JE Harrison
Calcified Tissue International 1981
Bone loss in adults receiving alternate day glucocorticoid therapy
OS Gluck, WA Murphy, TJ Hahn, B Hahn
Arthritis & Rheumatism 1981
Effects of hydrochlorothiazide and dietary sodium restriction on calcium metabolism in corticosteroid treated patients
JS Adams, TO Wahl, BP Lukert
Metabolism 1981
Metabolic bone disease: osteoporosis and osteomalacia
SR Goldring, SM Krane
Disease-a-Month 1981
Lack of effect of dexamethasone on the in vivo parathyroid hormone mediated generation of adenosine 3′, 5′-cyclic monophosphate in rat kidneys
IS Salti, MA Balaa, SI Butros
Journal of Endocrinological Investigation 1981
Comparison of subacute effects of oxazacort and prednisone on mineral metabolism in man
TJ Hahn, LR Halstead, B Strates, B Imbimbo, DT Baran
Calcified Tissue International 1980
6 Drug-induced disorders of vitamin D and mineral metabolism
TJ Hahn
Clinics in Endocrinology and Metabolism 1980
Glucocorticoid receptor in clonal osteosarcoma cell lines: A novel system for investigating bone active hormones
MR Haussler, SC Manolagas, LJ Deftos
Biochemical and Biophysical Research Communications 1980
Ergebnisse der Inneren Medizin und Kinderheilkunde / Advances in Internal Medicine and Pediatrics
P Frick, GA von Harnack, GA Martini, A Prader, HP Wolff
1980
Cushing’s Syndrome
DT Kishi
Journal of the American Pharmaceutical Association (1961) 1975
Corticosteroids
KM Hemrajani, NK Khanna
The Indian Journal of Pediatrics 1974

← Previous 1 2 3 4 5 6 … 10 11 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 clinical guideline sources
18 readers on Mendeley
See more details